British Diabetic Association guidelines on genetic and immune screening for type 1 diabetes mellitus.
The following article is a report from the Chairman of the Professional Advisory Committee of the British Diabetic Association. The committee, with the help of a number of experts currently working in the field, produced a set of guidelines intended for use by health care professionals on the issues around genetic screening for Type 1 diabetes mellitus. The guidelines were approved by the Board of Management of the British Diabetic Association and we publish them here.
Avery
L
L
Borsey
D Q
DQ
Greene
S A
SA
Gummerson
I
I
Hayes
R
R
Kerr
D
D
Lean
M E
ME
Marshall
S M
SM
McInnes
A
A
Pierce
M
M
Roland
J
J
Sinclair
A J
AJ
Tadman
J
J
Walton
A
A
Wiles
P
P
D001323:Autoantibodies / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis* / Q000235:genetics* / Q000276:immunology; D005820:Genetic Testing / Q000592:standards*; D006801:Humans; D008403:Mass Screening / Q000592:standards*; D009679:Nuclear Family; D012307:Risk Factors; D006113:United Kingdom
D001323:Autoantibodies